Lennart Hansson

Lennart Hansson's AcademicInfluence.com Rankings

Lennart Hansson

Philosophy

#5704

World Rank

#8586

Historical Rank

Logic

#2936

World Rank

#4015

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Lennart Hansson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lennart Hansson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial (1998) (5865)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (2004) (2115)
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial (1999) (2032)
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study (1999) (1470)
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial (2003) (1433)
Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. (1992) (986)
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study (2000) (950)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. (2003) (723)
Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. (1998) (656)
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial (2004) (612)
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. (1999) (557)
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial (2002) (528)
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. (2001) (499)
1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (1998) (308)
Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Commentary (1992) (268)
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. (2001) (267)
Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension–2 (2000) (222)
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial (2001) (218)
Study on COgnition and Prognosis in the Elderly (SCOPE). (2000) (204)
PROLONGED EXPOSURE TO A STRESSFUL STIMULUS (NOISE) AS A CAUSE OF RAISED BLOOD-PRESSURE IN MAN (1977) (172)
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. (1973) (168)
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
Capsaicin-induced cough in humans. (1992) (161)
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. (2001) (160)
The Hypertension Optimal Treatment study and the importance of lowering blood pressure. (1999) (157)
1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
Neurophysiology of the cough reflex. (1996) (138)
CORONARY HEART-DISEASE AFTER TREATMENT OF HYPERTENSION (1978) (137)
Home blood pressure determination. Value in borderline ("labile") hypertension. (1974) (136)
Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report (2002) (134)
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? (2003) (133)
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. (2009) (129)
Effects of Clonidine Withdrawal: Possible Mechanisms and Suggestions for Management (1973) (124)
Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. (1988) (119)
Relation of central hemodynamics to obesity and body fat distribution. (1992) (110)
Relation between drug treatment and cancer In hypertenslves in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial (2001) (106)
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study (2000) (104)
The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization (2004) (101)
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. (1990) (101)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Noise as a contributory factor in the development of elevated arterial pressure. A study of the mechanisms by which noise may raise blood pressure in man. (2009) (96)
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. (1992) (94)
Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. (2002) (90)
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (1998) (89)
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk (2003) (88)
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. (1994) (88)
Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial (2001) (86)
Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk (2002) (85)
Antihypertensive efficacy and side effects of three beta‐blockers and a diuretic in elderly hypertensives: a report from the STOP‐Hypertension study (1992) (82)
Effect of noise on blood pressure and 'stress' hormones. (1982) (80)
Risk assessment and treatment benefit in intensively treated hypertensive patients of the Hypertension Optimal Treatment (HOT) study (2001) (78)
Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. (1998) (77)
IMMUNOLOGICAL CHANGES IN PATIENTS WITH PREVIOUS MALIGNANT ESSENTIAL HYPERTENSION (1981) (77)
Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. (1973) (77)
The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. (1996) (77)
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study (2001) (73)
Regional sensitivity of human airways to capsaicin-induced cough. (1992) (72)
Controlled Trial of Nifedipine and Bendroflumethiazide in Hypertension (1983) (71)
Controlled study of atenolol in treatment of hypertension. (1975) (69)
Treatment of hypertension with propranolol and hydralazine. (2009) (67)
Circulatory effects of noise. (2009) (64)
Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline Characteristics (2000) (64)
Regression of left ventricular hypertrophy--a meta-analysis. (1992) (63)
Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma (2003) (63)
Excess Morbidity and Cost of Failure to Achieve Targets for Blood Pressure Control in Europe (2002) (63)
Malignant hypertension--improving prognosis in a rare disease. (2009) (63)
Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS (1996) (62)
Rationale for combination therapy. (1987) (61)
Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients. (1982) (56)
Relation of maternal blood pressure during pregnancy to birth weight and blood pressure in children. The Hypertension in Pregnancy Offspring Study (1994) (56)
Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. (1984) (55)
Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide (1992) (55)
Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. (1992) (54)
ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension. (1995) (53)
An international co-operative study on the relation of blood pressure to electrolyte excretion in populations. I. design and methods (1986) (53)
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk. (2004) (52)
Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response. (1974) (52)
Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human essential hypertension. (1976) (49)
Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost‐effectiveness of intensive blood pressure lowering and low‐dose aspirin in patients with hypertension (2003) (47)
Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD. (2002) (47)
Cognitive Function and Health-Related Quality of Life in Elderly Patients with Hypertension - Baseline Data from the Study on COgnition and Prognosis in the Elderly (SCOPE) (2002) (46)
The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender. (1995) (46)
Hypertension in polycystic kidney disease. (1974) (45)
Twice-daily propranolol treatment for hypertension. (1971) (44)
The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide (1993) (43)
Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. (1994) (42)
Circulatory effects of stress in essential hypertension. (2009) (42)
The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability. (1997) (41)
1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. (2000) (40)
Increased secretion of immunoglobulins in malignant hypertension (1989) (39)
International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease. (1987) (39)
Effects of inhaled lignocaine and adrenaline on capsaicin-induced cough in humans. (1994) (38)
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region (2005) (38)
Prediction of later hypertension following a hypertensive pregnancy. (1983) (38)
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. (2001) (38)
‘WHY DON'T YOU DO AS I TELL YOU?’ COMPLIANCE AND ANTIHYPERTENSIVE REGIMENS (2002) (37)
Primary Hypertension Refractory to Triple Drug Treatment: A Study on Central and Peripheral Hemodynamics (1978) (37)
Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension. (1996) (37)
Pharmacokinetic and pharmacodynamic parameters in patients treated with nitrendipine. (1983) (37)
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study (2002) (36)
Experience with nitrendipine--a new calcium antagonist--in hypertension. (1982) (34)
Influence of sex on blood pressure and left ventricular mass in adolescents: the Hypertension in Pregnancy Offspring Study. (1993) (34)
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. (2000) (34)
Oxygen desaturation during sleep and exercise in patients with interstitial lung disease. (1987) (33)
Predictors of stroke in the elderly. (2009) (33)
Regional sensitivity of the respiratory tract to stimuli causing cough and reflex bronchoconstriction. (1991) (32)
Blood pressure reduction and vascular adaptation. A study on long-term effects of treatment with mefruside or atenolol. (2009) (32)
Effect of coffee on ambulatory blood pressure in patients with treated hypertension (1993) (32)
Acute and Long‐Term Hemodynamic Effects of Carvedilol, a Combined &bgr;‐Adrenoceptor Blocking and Precapillary Vasodilating Agent, in Hypertensive Patients (1987) (32)
The optimal blood pressure reduction (1996) (31)
Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. (2009) (30)
Enhanced pressor responses to experimental and daily‐life stress in borderline hypertension (1995) (30)
Factors affecting the validity of the standard blood pressure cuff. (1993) (30)
Haemodynamic effects of noise exposure before and after beta 1-selective and non-selective beta-adrenoceptor blockade in patients with essential hypertension. (1981) (29)
Hemodynamic and hormonal changes induced by noise. (2009) (29)
Nocturnal hypoxaemia in severe scoliosis. (1988) (28)
Changes in transcutaneous PCO2 with sleep in normal subjects and in patients with chronic respiratory diseases. (1987) (28)
Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade. (1983) (26)
The reliability of auscultatory measurement of arterial blood pressure. A comparison of the standard and a new methodology. (1990) (26)
Effect of nedocromil sodium on the airway response to inhaled capsaicin in normal subjects. (1988) (26)
Five‐year follow‐up of blood pressure and left ventricular mass in children with different maternal histories of hypertension: the Hypertension in Pregnancy Offspring Study (1994) (26)
Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist. (2009) (26)
How far should blood pressure be lowered? What is the role of the J-curve? (1990) (24)
Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension. (2009) (24)
The effects of nitrazepam and flunitrazepam on oxygen desaturation during sleep in patients with stable hypoxemic nonhypercapnic COPD. (1989) (23)
Left ventricular hypertrophy and myocardial ischaemia in hypertension: the THAMES Study. (1993) (23)
Antihypertensive treatment and the prevention of dementia: further insights from the Syst-Eur trial. (1999) (23)
Antihypertensive Effect of Felodipine or Hydralazine When Added to β‐Blocker Therapy (1988) (23)
Antihypertensive Treatment: Does the J-curve Exist? (2000) (22)
Blood pressure does not predict mortality in the elderly (1988) (22)
Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent. (2009) (22)
CLINICAL ASPECTS OF BLOOD PRESSURE CRISIS DUE TO WITHDRAWAL OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS (1983) (22)
Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone system. (1996) (22)
How much should blood pressure be lowered? The problem of the J-shaped curve. (1989) (21)
Calcium antagonists combined with beta-blockers or ACE inhibitors in the treatment of hypertension. (1988) (21)
Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension. (1976) (21)
Blood pressure and left ventricular mass in children with different maternal histories of hypertension: the Hypertension in Pregnancy Offspring Study (1993) (20)
Urinary kallikrein excretion is low in malignant essential hypertension. (1992) (20)
Propranolol in hypertension (1972) (20)
Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol. (1987) (19)
Additive effect of isradipine in combination with captopril in hypertensive patients. (1989) (19)
Underestimation of the true benefits of antihypertensive treatment: an assessment of some important sources of error. (1997) (19)
Improved accuracy of indirect blood pressure measurement in patients with obese arms. (1993) (18)
Abnormal immune function in malignant hypertension (1993) (18)
Treatment of Hypertension With β‐Blockers With and Without Intrinsic Sympathomimetic Activity (1983) (18)
Results of the STOP-Hypertension-2 trial. (2000) (18)
Hypertension management in 2002: where have we been? where might we be going? (2002) (17)
IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
Interrelation of cardiac and vascular structure in young men with borderline hypertension. (1993) (17)
Hypertension Optimal Treatment (HOT) trial (1998) (17)
Comparison of guanadrel and guanethidine (1973) (17)
Borderline hypertension. Hypertension seminars at Ostra Hospital, Göteberg, Sweden. (2009) (17)
What are we really achieving with long-term drug therapy? (1988) (17)
Losartan in essential hypertension: Effects on blood pressure and left ventricular maass (1995) (16)
Different Haemodynamic Reaction Patterns during Noise Exposure in Normotensive Subjects with and without Heredity for Essential Hypertension (1982) (16)
The E.L.S.A. Trial: Protocol of a Randomized Trial to Explore the Differential Effect of Antihypertensive Drugs on Atherosclerosis in Hypertension (1994) (16)
Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics. (1981) (16)
Glucose and insulin levels in young subjects with different maternal histories of hypertension: The Hypertension in Pregnancy Offspring Study (1997) (15)
Human leucocyte antigens in patients with previous essential malignant hypertension. (1980) (15)
Calcium Antagonists in Hypertension: Update 1986 (1987) (15)
Cardiovascular responses to stress in young hypertensive women. (1992) (15)
Long-term renal preservation in essential hypertension: Angiotensin converting enzyme inhibition is superior to β-blockade☆ (1996) (15)
Morbidity and mortality with dihydropyridines. (1998) (15)
Review of state-of-the-art beta-blocker therapy. (1991) (14)
Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
23 ELSA, European Lacidipine Study on Atherosclerosis (1993) (14)
Stress and platelet activation. (1983) (14)
Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients. (1996) (14)
Future goals for the treatment of hypertension in the elderly with reference to STOP-Hypertension, SHEP, and the MRC trial in older adults. (1993) (14)
Beta-adrenergic blockade in hypertension. (1977) (14)
Renal aspects of the Hypertension Optimal Treatment (HOT) Study (1996) (14)
Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume. (1975) (14)
The Relationship between Dose and Antihypertensive Effect for Different AT 1 -receptor Blockers (2001) (13)
Vasodilators in hypertension--a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers. (1985) (13)
Results of the STOP-Hypertension-2 Trial (2000) (13)
The incidence of ECG abnormalities in acute cerebrovascular accidents. (2009) (13)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Effects of treatment with nifedipine and metoprolol in essential hypertension (2004) (13)
Homocysteine and ADMA--emerging risk factors for cardiovascular disease? (2002) (13)
Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. (1982) (13)
Therapy of hypertension and metabolic syndrome: today's standard and tomorrow's perspectives. (1998) (12)
Blood pressure over-shoot due to acute clonidine (Catapres) withdrawal: studies on arterial and urinary catecholamines and suggestions for management of the crisis. (1973) (12)
Correspondence between screening and intra‐arterial blood pressures in young men with borderline hypertension (1993) (12)
Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project. (1999) (12)
Regression of structural cardiovascular changes by antihypertensive therapy. (1984) (12)
Controlled trial of enalapril and hydrochlorothiazide in 200 hypertensive patients. (1988) (12)
Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients (2004) (11)
The use of propranolol in hypertension: a review. (1976) (11)
Hemodynamics of prehypertension and hypertension. (1974) (11)
Renal function as an indicator of prognosis in malignant essential hypertension. (1982) (11)
VIEWPOINT The Antiatherosclerotic Effect of Calcium Antagonists in Man—What did MIDAS Actually Show? (1995) (11)
Calcium Antagonists in Antihypertensive Combination Therapy (1991) (11)
Carvedilol in the treatment of hypertension--a review of the clinical data base. (1998) (11)
Assessment of Hypertensive Organ Damage (1997) (11)
Calcium antagonists in the treatment of hypertension: state of the art. (1990) (10)
Hypertension in pregnancy. Analysis of 261 consecutive cases. (1986) (10)
REGRESSION OF LEFT VENTRICULAR HYPERTROPHY (1992) (10)
Long-term experience with the combination of pindolol and isradipine in essential hypertension (1988) (10)
Characteristics of Hypertension in Pregnancy (1984) (10)
Long-term effects of captopril and atenolol in essential hypertension. (2009) (10)
Estrogen and progestagen modify the hemodynamic response to mental stress in young women (1996) (10)
Maternal hypertension during pregnancy and high blood pressure in children. Preliminary communication. (1983) (10)
HAPPHY trial: primary prevention against coronary heart disease with beta-blockers ruled out by HAPPHY? (1987) (10)
Predictors of blood pressure and left ventricular mass in the young: the Hypertension in Pregnancy Offspring Study. (1994) (10)
Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects. (2009) (9)
Success in the treatment of hypertension: a status report. (1997) (9)
Haemodynamic effects of loud noise in hypertensive patients treated with combined beta-adrenoceptor blockade and precapillary vasodilatation. (1984) (9)
The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study. (1995) (9)
Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients (2004) (9)
Blood Pressure Measurement: A Century of Achievements and Improvements in the Year 2002 (2002) (9)
Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent. (1974) (9)
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol (1976) (9)
Regression of Structural Alterations of Hypertension with Calcium Antagonists - Vascular Hypertrophy (1987) (9)
Reversal of cardiac and vascular hypertrophy by antihypertensive therapy. (1991) (9)
Current and future strategies in the treatment of hypertension. (1988) (9)
Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide. (1985) (8)
The Captopril Prevention Project (CAPPP): description and status. (1994) (8)
Swedish Isradipine Study in Hypertension: Evaluation of Quality of Life, Safety, and Efficacy (1991) (8)
Borderline hypertension. A 24-hour abnormality. (1993) (8)
Calcium antagonists: an overview. (1991) (8)
Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors. (1979) (8)
Treatment of Hypertension and the J Curve. (1999) (8)
Study on COgnition and Prognosis in the Elderly (SCOPE): Design and Objectives (2000) (8)
Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes. (1986) (8)
Arterial hypotension and its consequences for the cerebral circulation. (2009) (8)
The place of β-blockers in the treatment of hypertension in 1993 (1993) (7)
How far Should we Lower Blood Pressure in the Elderly (2004) (7)
Possible relationship between psycho-emotional factors and haemodynamic patterns in the pathogenesis of mild blood pressure elevation. (1981) (7)
Blood pressure and response to "stress" in 11-16 year old children. (2009) (7)
PROGRESS – perindopril protection against recurrent stroke study: status in July 1996 (1996) (7)
Beta-blockers with ACE inhibitors--a logical combination? (1989) (7)
Cerebrovascular lesions. Active antihypertensive treatment and the present situation. (2009) (6)
Heart rate responses during treatment of hypertension with propranolol; The clinical usefulness of the nitroglycerin test (1976) (6)
Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension. (2009) (6)
Clinical studies with candesartan. (1999) (6)
1991 Guidelines for the prevention of hypertension and associated cardiovascular disease (1992) (6)
Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade. (1996) (6)
Captopril or atenolol in essential hypertension. (2009) (6)
Comparison of Home and Office Blood Pressure in Treated Hypertensives in the Nordic Diltiazem (NORDIL) Study (2002) (6)
Evaluation of endpoints in hypertension. (1997) (6)
The key issues in preventive cardiology. (1992) (6)
Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent. (1976) (6)
Hypertension and coronary heart disease: cause and consequence or associated diseases? (1984) (6)
Cardiac involvement in hypertension (1982) (5)
ADVANTAGES AND DISADVANTAGES OF THE META-ANALYSIS APPROACH. DISCUSSION (1996) (5)
Improved blood pressure control with isradipine in hypertensive patients treated with pindolol. (1989) (5)
Prevention of coronary heart disease: the recommendations of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. (1995) (5)
Assessment of the patient's response. (1985) (5)
Cardiac involvement in hypertension. A non-invasive study of patients with previous malignant hypertension and 'benign' hypertension. (1982) (5)
Primary hypertension refractory to triple drug treatment - a study on central and peripheral hemodynamics. (2009) (5)
A Clinical Follow-Up Study of 260 Women with Hypertension in Pregnancy (1983) (5)
Review of studies with urapidil in elderly hypertensives. (1995) (5)
Positive Relationship Between the Dosage of Pindolol and Its Antihypertensive Effect (1982) (5)
Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension. (1987) (4)
The Effect of Dihydropyridine Calcium Antagonists in Hypertensive Patients with Impaired Renal Function (1989) (4)
THE VALSARTAN ANTIHYPERTENSIVE LONGTERM USE EVALUATION (VALUE) TRIAL: FINAL PATIENTS DEMOGRAPHICS (2000) (4)
Capsaicin-induced Cough in Humans 1 • 2 (1992) (4)
First-line antihypertensive therapy [letter] (2000) (4)
Pafenolol in Hypertension: A Double-Blind Randomized Trial of a New β1-Selective Adrenoceptor Blocker (1986) (4)
Is blood pressure measurement with a standard cuff reliable? (1992) (4)
Cerebrovascular risk factors are determinants of low cognitive function: A 20-year follow-up of 999 elderly men (1999) (4)
Implications of doxazosin therapy on risk of coronary heart disease. (1988) (4)
[The long-term treatment of hypertension in 158 patients with propranonol]. (1971) (4)
First-line antihypertensive therapy (2000) (4)
Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate. (1995) (4)
The long-term effect of isradipine in pindolol-treated patients. (1987) (4)
Clinical evaluation of atenolol in hypertension. (1976) (4)
European Society of Hypertension Scientific Newsletter, Update on Hypertension Management: Treatment of hypertension in patients with type‐2 diabetes mellitus (2000) (4)
International views of the use of calcium antagonists in the treatment of hypertension. (1985) (4)
Negative consequences of blood pressure reduction. (2009) (4)
Effects of single doses of propiomazine, a phenothiazine hypnotic, on sleep and oxygenation in patients with stable chronic obstructive pulmonary disease. (1990) (4)
Treatment of hypertension in the elderly with special reference to urapidil. (1994) (4)
Blockers in Hypertension (1987) (4)
Mechanisms in hypertension : new aspects in hemodynamics (1989) (3)
[Stimulation of the sinus nerves with an implanted baropacer in patients with therapy-resistant hypertension]. (1973) (3)
88 The Hypertension Optimal Treatment (HOT) study purpose and design (1993) (3)
A clinical follow-up study of 260 women with hypertension in pregnancy. (1984) (3)
THE EFFECT OF PROPRANOLOL ON PLASMA RENIN ACTIVITY AND BLOOD PRESSURE IN MILD ESSENTIAL HYPERTENSION (2009) (3)
The place of beta-blockers in the treatment of hypertension in 1993. (1993) (3)
ISA--vasodilatation: improvement of organ perfusion. (1987) (3)
NEUROPHYSIOLOGY OF THE COUGH REFLEX. AUTHOR'S REPLY (1996) (3)
Hypertension-induced congestive heart failure. (1998) (3)
Blood pressure and serum lipids in hypertensive men and women aged 60-97 years. (1995) (3)
Isolated systolic hypertension (1987) (3)
Hypertension in the elderly (1996) (3)
Cardioprotective potential of antihypertensives. (1995) (3)
A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol. (1982) (3)
Hypertension in the elderly: state-of-the-art treatment. (1998) (3)
Risk of major gastrointestinal bleeding with aspirin (1999) (3)
Antihypertensive Effect of Prizidilol (1983) (3)
What have we learned from the HOT (Hypertension Optimal Treatment) study? (1997) (3)
EDITORIAL The growing importance of systolic blood pressure (1998) (3)
Shortcomings of current antihypertensive therapy. (1991) (3)
INSIGHT and NORDIL (2000) (3)
Beta-Adrenoceptor Blocking Drugs As Antihypertensive Agents (1982) (3)
Isradipine: a profile in essential hypertension (1993) (3)
The Rationale for Ketanserin Therapy in Hypertension (1987) (3)
HYPERTENSION OPTIMAL TREATMENT (HOT) TRIAL. AUTHORS' REPLY (1998) (3)
The future role of losartan. (1995) (3)
Relationship between change in erythrocyte sodium and antihypertensive response to enalapril. (1994) (2)
Analysis of treatment outcomes. Why is benefit not larger? (1989) (2)
Factors in the selection of a new antihypertensive and anti‐anginal drug (1988) (2)
Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade. (1973) (2)
HANDBOOK OF HYPERTENSION (1984) (2)
Introduction: Position of beta blockers in antihypertensive therapy (1986) (2)
Dissociation of the renin lowering and antihypertensive actions of propranolol. (1976) (2)
95. Haemodynamic stress responses in hypertensive women during the menstrual cycle (1991) (2)
Treatment of hypertension in patients with type-2 diabetes mellitus. (2000) (2)
Major antihypertensive intervention trials conducted outside the United States. (1996) (2)
Position of beta blockers in antihypertensive therapy. (1986) (2)
Key learnings from the STOP-Hypertension study: An update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly (2004) (2)
Introduction: the role of combination therapy in modern antihypertensive therapy. (2000) (2)
Treatment of Hypertension in the Elderly (1993) (2)
Medical and cost-economy aspects of modern antihypertensive therapy--with special reference to 2 years of clinical experience with losartan. (1997) (2)
Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
Endothelial Dysfunction - A Challenge for Hypertension Research (2000) (2)
Pre‐eclampsia, hypertension and the premenstrual tension syndrome (1990) (2)
Effects of beta-adrenoceptor blocking agents on haemodynamic parameters. (2009) (2)
Does drug treatment improve survival in mild-to-moderate hypertension? (1995) (2)
Status of current therapies for hypertension. (1995) (2)
Low erythrocyte Na+/K+ ratio in children with mild blood pressure elevation and a positive family history of hypertension. (1984) (2)
Antihypertensive therapy-a viable branch of medicine and Obituary (1997) (2)
Concluding Remarks (1999) (2)
What does STOP-2 tell us about management of hypertension? (2000) (2)
Cardiovascular risk factors and antihypertensive treatment. (1992) (2)
Aims of Treatment of Hypertension (1987) (2)
On Salt and Treatment Goals in Hypertension: Time for Reappraisal? (1992) (2)
J curve relation between diastolic blood pressure and myocardial infarction. (1989) (1)
Mortality matters. (1994) (1)
Hypertensive therapy--effect on coronary risk factors. (1992) (1)
Strong evidence that antihypertensive pharmacologica treatment reduces cardiovascular morbidity and mortality (1999) (1)
MICROALBUMINURIA IN ESSENTIAL HYPERTENSION AND DIABETES MELLITUS. DISCUSSION (1996) (1)
Issues in the treatment of hypertension: current and future perspectives. (1997) (1)
[Effect of intensive antihypertensive treatment and of aspirin in a low dose in the hypertensive. The HOT (Hypertension Optimal Treatment) study]. (1999) (1)
The impact of antihypertensive therapy in type 2 diabetes (2000) (1)
[Vascular surgery or amputation in critical extremity ischemia?]. (1988) (1)
The J-shaped curve and how far should blood pressure be lowered? (1995) (1)
Circulatory aspects of hypertension. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. (2009) (1)
Vasodilatation and beta-adrenoceptor blockade in hypertension: A double-blind comparison between prizidilol and propranolol plus hydralazine (1983) (1)
Methodological aspects: general discussion (1996) (1)
Adrenergic agents: clinical trials and experiences. (1992) (1)
P-453 *Program Revision (see p. 267A): Gender specific characteristics of 15,288 hypertensive patients at high coronary risk. The value trial (2001) (1)
Is Hypertension Treated Adequately? (2012) (1)
Antipathological potential of beta-blockers. (1989) (1)
Treatment of hypertension in the elderly. (1993) (1)
ACE Inhibitor as One of Several Possible First-Line Agents Is Reasonable for Diabetic Patients With Hypertension (2002) (1)
Influence of age and gender on preventing myocardial infarction by antihypertensive treatment and aspirin in the hot study. (1999) (1)
How far should blood pressure be lowered? What is the importance of the J-curve phenomenon? (1990) (1)
Predicted reductions in the risk of coronary heart disease by antihypertensive therapy: the confounding effect of lipids (1990) (1)
Failure of randomisation by “sealed” envelope (1999) (1)
Beta‐blockers and related drugs for the treatment of hypertension (1988) (1)
How to study the role of hypertension in atherosclerosis. Lessons from MIDAS. Multicentre Isradipine Diuretic Atherosclerosis Study. (1996) (1)
Peripheral vascular changes after treatment of severe hypertension (1982) (1)
Combination therapy with saluretics and atenolol in essential hypertension. Effects on blood pressure, electrolytes and uric acid. (2009) (1)
"Stress" and hypertension. (2009) (1)
Sympathetic nervous system: The link between heart failure, hypertension, and NIDDM: Proceedings from a satellite symposium at the XIXth congress of the European Society of Cardiology (ESC), held in Stockholm, Sweden, August 27, 1997. Introduction (1998) (1)
Treatment of Hypertension with Calcium Antagonists (1989) (1)
152 Additive effect of isradipine in combination with captopril in hypertensive patients (1988) (1)
The value trial: patients demographics and progress report. (1999) (1)
A hemodynamic study of arteriolar changes in patients with previous malignant hypertension. (2009) (1)
The Parathyroid Hypertensive Factor: Important Evidence Is Accumulating (1993) (1)
98 The cost-effectiveness of treating hypertension in the elderly: an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) (1993) (1)
[BBB--a Swedish multicenter study. Can hypertension be better treated?]. (1988) (0)
The medullipin system of blood pressure control (1997) (0)
Treatment of isolated systolic hypertension. (1994) (0)
Prediction of insulin resistance [editorial; comment] (1996) (0)
Book Review (2002) (0)
58 A five-year follow-up after withdrawal of treatment in elderly hypertensives (1993) (0)
[Review of new pharmacological treatment principles in hypertension]. (1983) (0)
METHODOLOGICAL ASPECTS : GENERAL DISCUSSION. DISCUSSION (1996) (0)
Combined Action Drugs in the Treatment of Hypertension (2012) (0)
Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
Headache, Hypertension, and Irbesartan Therapy—Reply (2001) (0)
The Future of Pharmacological Therapy for Risk Factor Reduction (2012) (0)
Hypertension guidelines and goals of treatment: role of calcium antagonists. (2000) (0)
Postmenopausal Hormone Replacement Therapy and Hypertension (2000) (0)
Monotherapy vs combined treatment in hypertension: new clinical trials data. (2001) (0)
Satellite Symposium on Do European Hypertensive Patients Get Optimal Treatment? at XXth Congress of the European Society of Cardiology, Vienna, Austria, 22 August 1998: Introduction (1998) (0)
Choice of initial therapy: new clinical trials data (2002) (0)
[Hypertensive crises are rare conditions. Uncritical use of intravenous antihypertensive agents can be more harmful than useful]. (1986) (0)
ACE inhibition and left ventricular remodelling. (1997) (0)
Letter to the members of the International Society of Hypertension (1989) (0)
The hypertension optimal study (1998) (0)
27. Retinal vascular changes: different effects of enalapril and hydrochlorothiazide in previously untreated patients with non-malignant hypertension (1991) (0)
72. Left ventricular mass in children with different maternal background for hypertension (1991) (0)
Comparison of meta-analyses of therapeutic studies on regression of left ventricular hypertrophy. (1997) (0)
Reaching BP targets : physicians' flexibility with therapy : based on a satellite symposium held at the XXIst Congress of the European Society of Cardiology, Barcelona, Spain, 28 August 1999 (2000) (0)
Choosing the optimal antihypertensive dose regimen (1995) (0)
COST-EFFECTIVENESS CALCULATIONS FROM TRIALS. DISUCUSSION (1996) (0)
CAPTOPRILAND ATENOLOL COMBINED WITH HYDROCHLOROTHIAZIDE INESSENTIALHYPERTENSION (1982) (0)
Cognitive function/dementia: Thursday, may 18, broadway ballroom south, 10:30 am to 12:30 pm. theme iii: hypertension: markers, risk factors and outcomes (2000) (0)
Evaluation of the hypertensive patient (1996) (0)
44 STOP-Hypertension 2 (1993) (0)
Update of the Latest Intervention Trials in Hypertension and Type 2 Diabetes (2000) (0)
[Round table on Hypertension and coronary heart disease: new trends in treatment]. (1984) (0)
General Considerations When Treating Hypertension (2012) (0)
B028: Study on cognition and prognosis in the elderly (SCOPE). evaluation of risk factors (2000) (0)
Wednesday, 5/17, Trianon, 8:30 am–11:30 am Unresolved Issues in the Treatment of HypertensionNew Trials of Antihypertensive Drugs Outside the United States (1995) (0)
[Mild hypertension--risks and therapeutic strategies]. (1984) (0)
43 A blood pressure fall is not the only factor of importance in the reversal of cardiac hypertrophy (1993) (0)
Treatment of Hypertension with β-Blockers in Elderly Patients (1982) (0)
Erythrocyte sodium transport in malignant hypertension (1990) (0)
Characteristics of an ideal antihypertensive therapy for elderly hypertensives. (1995) (0)
[Experiences with a portable semi-automatic blood pressure recorder]. (1979) (0)
9. Correspondence between screening and intra-arterial blood pressures in young men with borderline hypertension (1991) (0)
78. The SWISH study (Swedish Isradipine Study in Hypertension): evaluation of quality of life and efficacy in 587 patients (1991) (0)
Lessons from STOP-Hypertension (1994) (0)
D047 Study on cognition and prognosis in the elderly (SCOPE). Design and objectives (1998) (0)
Impact of antihypertensive drugs on the cardiovascular patient. (1987) (0)
[Not much news for Sweden in new international hypertension guidelines]. (1990) (0)
Intermediate cardiovascular end points in therapeutic trials (1997) (0)
Smoking affects blood pressure [editorial] (1996) (0)
Researchers Receive Record Compensation from TV Company for Media Insult Linked to the Calcium Antagonist Controversy (2002) (0)
Editorial: Prediction of insulin resistance (1996) (0)
D012 Valsartan antihypertensive longterm use evaluation (the value study) (1998) (0)
Antihypertensive drugs and plasma lipids. (1992) (0)
17 Considerable reduction of blood pressure and significant reduction of left ventricular mass when adding isradipine in hypertensive men treated with a beta-blocker (1993) (0)
POST HOC ANALYSIS : USE AND DANGERS IN PERSPECTIVE. DISCUSSION (1996) (0)
P-225: Predictors of one year blood pressure control and treatment resistance in the value trial (2002) (0)
76 Suppressed male sex steroid hormones in borderline hypertension (1993) (0)
Hypertension and the heart. Advances in experimental medicine and biology (1997) (0)
Benefits and risks of treating hypertension in the elderly (1995) (0)
Treatment of hypertension--risk/benefit: excerpts of a panel discussion. (2009) (0)
Editorial: Hypertension Management in Practice - Priorities and Problems (1998) (0)
Beta-blockers in hypertension. (1987) (0)
Blood pressure and coronary heart disease [editorial; comment] (1999) (0)
Clinical trials in progress with antihypertensive therapy (1995) (0)
THE HYPERTENSION TRIALS. DISCUSSION (1996) (0)
25. Different effects of enalapril and hydrochlorothiazide on left ventricular structure: a controlled study of untreated hypertensives (1991) (0)
134 High blood pressure, but not smoking habits, predicts the risk of stroke in an elderly population (1988) (0)
THE OPTIMAL BLOOD PRESSURE REDUCTION. DISUCSSION (1996) (0)
The case for a greater blood pressure fall. (1996) (0)
CAPPP trial (1999) (0)
The impcat of systolic blood pressure control in angiotensin II antagonist blockade (2001) (0)
Blood pressure--then and now [editorial] (1996) (0)
87 Cardiovascular morbidity and mortality in the BBB study (1993) (0)
Antihypertensive therapy--a viable branch of medicine [editorial] (1997) (0)
BENEFITS AND RISKS OF LOW-DOSE ASPIRIN IN DIFFERENT GROUPS OF HYPERTENSIVE PATIENTS IN THE HOT STUDY: P2.13 (2000) (0)
Intervention trials in hypertension. An update on the status of ongoing studies (1996) (0)
The Art of Prediction and Prevention (1994) (0)
Evaluation of end-points in hypertension (1997) (0)
[Healthy persons are classified as hypertensive due to faulty equipment for blood pressure determination]. (1989) (0)
[A review of recent pharmacological therapeutic principles in hypertension]. (1983) (0)
Current intervention trials with ACE inhibitors in hypertension (1996) (0)
Modern combination therapy: the way forward in the management of hypertensive patients. Proceedings of an international symposium. Barcelona, Spain, 1-2 November 1996. (1997) (0)
Evaluation of the hypertensive subject (1990) (0)
D7 - The “hot” study; a large international prospective trial to evaluate the “J” curve during treatment of hypertension (1995) (0)
Hypertension Control for a New Era: Emerging Differences among AIIRAs (2001) (0)
Combination therapy for stroke: Lessons from STOP-Hypertension (1997) (0)
[Aortic coarctation - a neglected cause of hypertension?]. (1983) (0)
Dr Lowe has received funding for investigator-initiated (2002) (0)
Twenty-four hour blood pressure control : Clinical importance, measurement, and antihypertensive efficacy (1997) (0)
B017: The valsartan antihypertensive longterm use evaluation (VALUE) trial: Final patients demographics (2000) (0)
Isradipine in Hypertension (2012) (0)
HYPERTENSIOh IN POLYCY STIC KIDNEY DISEASE (2013) (0)
The hypertension optimal treatment (hot) study — Home BP in treated hypertensives (1997) (0)
Book Review (2001) (0)
INTENSIVE BLOOD PRESSURE LOWERING: CONTRAST BETWEEN BENEFITS IN DIABETICS AND OTHER GROUPS OF HYPERTENSIVE PATIENTS AND INCREASED RISK IN SMOKERS (2000) (0)
[Does antihypertensive treatment reduce the incidence of coronary disease?]. (1984) (0)
Update on stop-hypertension (1995) (0)
Antihypertensive therapy: Efficacy and tolerability in the elderly (1997) (0)
Blood pressure @ Internet-www.bloodpressure.nu [editorial] (2000) (0)
Treatment of Hypertension in the Elderly and Its Effect on Stroke (1994) (0)
[Clinical testing of a new beta blocking agent--atenolol--in hypertension]. (1976) (0)
CV6: EXCESS MORBIDITY AND COST OF FAILING TO ACHIEVE TARGETS FOR BLOOD PRESSURE CONTROL IN THE ELDERLY (2001) (0)
Hypertension--interaction with other coronary heart disease risk factors. (1992) (0)
Report from the First Meeting of the International Forum for Evaluation of Cardiovascular Care (IFECC) in 1990 (1990) (0)
92 Five-year tracking of blood pressure and cardiac structures in children with a different maternal background of hypertension: the Hypertension in Pregnancy Offspring Study (1993) (0)
Long-term benefits of antihypertensive treatment (1998) (0)
Editorial: Blood Pressure—Then and Now (1996) (0)
[Various beta-receptor blockaders affect hemodynamics in different ways]. (1982) (0)
Blood Pressure Risks and Awards (1995) (0)
Should a modern antihypertensive drug possess cardioprotective properties? (1997) (0)
Ten years of BLOOD PRESSURE—Looking back and forward (2001) (0)
The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension. (1974) (0)
[Many physicians do not measure blood pressure and do not know their own blood pressure status]. (1980) (0)
PRINCIPAL RESULTS OF THE NORDIL HYPERTENSION TRIAL – A COMPARISON BETWEEN DILTIAZEM AND DIURETIC/BETABLOCKER BASED TREATMENT: P2.46 (2000) (0)
26. Effect of first line antihypertensive therapy on cardiac hypertrophy: a meta-analysis of 1141 patients (1991) (0)
Antihypertensive effect of atenolol--a Swedish multicentre study. (1977) (0)
Hypertension and the Heart (1997) (0)
67. Reduction in blood pressure and adverse effects in the Behandla Blodtryck Battre Study (1991) (0)
Current problems in clinical hypertension: summary of a workshop held in Martinique, 29-31 October 1989. (1990) (0)
The forgotten significance of heart rate in cardiovascular disease : implications of chronotherapeutics : proceedings of a satellite symposium held at the XXth congress of the European Society of Cardiology, Vienna, Austria, 22 August 1998 (1999) (0)
Treatment of Hypertension in the and Its Effect on Stroke Elderly (2006) (0)

This paper list is powered by the following services:

Lennart Hansson's Academic­Influence.com Rankings

Why Is Lennart Hansson Influential?

Lennart Hansson's Published Works

Published Works

Lennart Hansson's AcademicInfluence.com Rankings